Cutting edge communication: Characterization of a new monoclonal antibody 6G7 that recognizes a unique antigen on myeloid and lymphoid cells

Journal of Hematotherapy and Stem Cell Research

Volumn 10, Issue 2, 2001, Pages 237-246

  Chen, J ^a   Zhou, J H ^a   Ball, E D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOTOXIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 6G7; RICIN A; UNCLASSIFIED DRUG; MEMBRANE ANTIGEN; TUMOR ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; BLAST CELL; BLOOD; BONE MARROW; BONE MARROW CELL; BURKITT LYMPHOMA; CELL CULTURE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DRUG CYTOTOXICITY; FEMALE; FOLLICULAR LYMPHOMA; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LEUKEMIA CELL LINE; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ADULT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STRAIN HL 60; CELL STRAIN K 562; CELL STRAIN U937; CHILD; IMMUNOLOGY; LEUKEMIA; LYMPHOCYTE; LYMPHOMA; MONOCYTE; PATHOLOGY;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; B-LYMPHOCYTES; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; HL-60 CELLS; HUMANS; IMMUNOPHENOTYPING; K562 CELLS; LEUKEMIA; LYMPHOCYTES; LYMPHOMA; MONOCYTES; TUMOR CELLS, CULTURED; U937 CELLS;

EID: 0035011792     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/15258160151134926     Document Type: Article

References (21)

1. Continuous cultures of fused cells secreting antibody of predefined specificity
2. Monoclonal antibody-based therapies for hematologic malignancies
3. Antigenic analysis of hematopoiesis III: A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells
4. Reversible expression of CD34 by murine hematopoietic stem cells
5. Clinicopathologic and cytogenetic features of CD34 (MY-10)-positive acute nonlymphocytic leukemia
6. Surface marker expression in adult acute myeloid leukemia: Correlation with initial characteristics, morphology and response to therapy
7. Prognostic importance of immunophenotyping in adults with acute myeloid leukemia: The significance of the stem-cell glycoprotein CD34 (MY-10)
8. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia
9. A rapid method for isolation of functional thymus-derived murine lymphocytes
10. Long-term culture of human bone marrow cells
11. Methodology of long-term culture of human hemotopoietic cells
12. Non-lineage antigens
13. Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell Non-Hodgkin's lymphoma
14. Anti B4-blocked ricin: A phase II trial of 7 day continuous infusion in patients with multiple myeloma
15. Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin
16. 131I-anti-CD45 antibody plus cyclophosphade and total body irradiation for advanced acute leukemia and myelodysplastic syndrome
17. Humanized monoclonal anti-CD33 antibody HuM195 in the treatment of relapsed/refractory acute myelogenous leukemia (AML): Preliminary report of a phase II study
18. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: Identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants
19. Alloreactive cytolytic T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens: Selective involvement of CD8 in the class I-directed cytotoxicity
20. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients
21. Prevention of graft-versus-host disease in high-risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft